These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1444305)

  • 1. Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B.
    Ghannoum MA; Filler SG; Ibrahim AS; Fu Y; Edwards JE
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2239-44. PubMed ID: 1444305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the new triazole, voriconazole (UK-109,496), on the interactions of Candida albicans and Candida krusei with endothelial cells.
    Fratti RA; Belanger PH; Sanati H; Ghannoum MA
    J Chemother; 1998 Feb; 10(1):7-16. PubMed ID: 9531069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.
    Van 't Wout JW; Meynaar I; Linde I; Poell R; Mattie H; Van Furth R
    J Antimicrob Chemother; 1990 May; 25(5):803-11. PubMed ID: 2165051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans.
    Burgess DS; Hastings RW; Summers KK; Hardin TC; Rinaldi MG
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):13-8. PubMed ID: 10744363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.
    van Etten EW; van de Rhee NE; van Kampen KM; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2275-81. PubMed ID: 1804000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro interaction of fluconazole and amphotericin B administered sequentially against Candida albicans: effect of concentration and exposure time.
    Ernst EJ; Klepser ME; Pfaller MA
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):205-10. PubMed ID: 9884837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
    Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 1998 May; 27(5):213-9. PubMed ID: 9682984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans.
    Khan MS; Malik A; Ahmad I
    Med Mycol; 2012 Jan; 50(1):33-42. PubMed ID: 21756200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal susceptibility testing of Candida albicans by flow cytometry.
    Gökahmetoglu S; Nedret Koç A; Patiroglu T
    Mycoses; 2003 Sep; 46(8):307-11. PubMed ID: 12950899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.
    Klepser ME; Wolfe EJ; Jones RN; Nightingale CH; Pfaller MA
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1392-5. PubMed ID: 9174207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
    Barchiesi F; Di Francesco LF; Compagnucci P; Arzeni D; Giacometti A; Scalise G
    J Antimicrob Chemother; 1998 Jan; 41(1):59-65. PubMed ID: 9511038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-antifungal effect and adhesion to buccal epithelial cells of oral Candida dubliniensis isolates subsequent to limited exposure to amphotericin B, ketoconazole and fluconazole.
    Ellepola AN; Chandy R; Khan ZU
    J Investig Clin Dent; 2015 Aug; 6(3):186-92. PubMed ID: 24850753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of Candida albicans, Austria 1992.
    Allerberger F; Fassl A; Niederwieser D; Zangerle R; Lingnau W; Dierich MP
    Mycoses; 1993; 36(11-12):411-6. PubMed ID: 7935573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model.
    Lewis RE; Lund BC; Klepser ME; Ernst EJ; Pfaller MA
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1382-6. PubMed ID: 9624480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans.
    Hirasawa M; Takada K
    J Antimicrob Chemother; 2004 Feb; 53(2):225-9. PubMed ID: 14688042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
    Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
    Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Antifungal Activity of Chitosan with Fluconazole against
    Lo WH; Deng FS; Chang CJ; Lin CH
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33153228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of incubation time and buffer concentration on in vitro activities of antifungal agents against Candida albicans.
    Tornatore MA; Noskin GA; Hacek DM; Obias AA; Peterson LR
    J Clin Microbiol; 1997 Jun; 35(6):1473-6. PubMed ID: 9163465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of antifungal additives in Optisol-GS corneal storage medium.
    Layer N; Cevallos V; Maxwell AJ; Hoover C; Keenan JD; Jeng BH
    JAMA Ophthalmol; 2014 Jul; 132(7):832-7. PubMed ID: 24789459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.